| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 679,979 | $47,078,890 | $69.24 | 29 Oct 2025 | By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 |
| BridgeBio Pharma, Inc. | Director | Common Stock | 83,275 | $4,325,303 | $51.94 | 29 Oct 2025 | Direct |
| BridgeBio Oncology Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 91,076 | 26 Aug 2025 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 84,814 | 05 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 29 Oct 2025 | 5 | -$13,206,528 | 4 | Director | 31 Oct 2025, 16:38 |
| BBIO | BridgeBio Pharma, Inc. | 27 Oct 2025 | 1 | -$106,665 | 4 | Director | 29 Oct 2025, 17:10 |
| BBIO | BridgeBio Pharma, Inc. | 05 Sep 2025 | 3 | -$3,051,464 | 4 | Director | 08 Sep 2025, 18:06 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 26 Aug 2025 | 1 | $0 | 4 | Director | 28 Aug 2025, 16:43 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 11 Aug 2025 | 0 | $0 | 3 | Director | 18 Aug 2025, 17:17 |
| BBIO | BridgeBio Pharma, Inc. | 24 Jun 2025 | 1 | -$4,422,800 | 4 | Director | 26 Jun 2025, 17:08 |
| BBIO | BridgeBio Pharma, Inc. | 20 Jun 2025 | 2 | $0 | 4 | Director | 24 Jun 2025, 19:07 |
| BBIO | BridgeBio Pharma, Inc. | 07 May 2025 | 2 | $0 | 4 | Director | 09 May 2025, 18:00 |
| BBIO | BridgeBio Pharma, Inc. | 26 Dec 2024 | 1 | $0 | 4/A | Director | 08 Jan 2025, 17:43 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 17:39 |
| BBIO | BridgeBio Pharma, Inc. | 26 Dec 2023 | 1 | -$4,206,000 | 4 | Director | 28 Dec 2023, 16:00 |
| BBIO | BridgeBio Pharma, Inc. | 21 Feb 2023 | 0 | $0 | 3 | Director | 28 Feb 2023, 20:52 |
| BBIO | BridgeBio Pharma, Inc. | 21 Feb 2023 | 1 | $0 | 4 | Director | 23 Feb 2023, 18:56 |